The role of facebook support groups for women with benign urologic conditions.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
Nov 2023
Historique:
revised: 25 08 2023
received: 17 06 2023
accepted: 31 08 2023
medline: 31 10 2023
pubmed: 14 9 2023
entrez: 14 9 2023
Statut: ppublish

Résumé

To understand the availability and content of patient support groups on social media platforms. Five prevalent benign, urologic conditions affecting adult women were selected for analysis. Facebook support groups for these conditions were identified. Groups specific to one urologic condition and with at least 400 members were included, and groups for pediatric and malignant conditions were excluded. Each support group was analyzed for member count, posts per month, and period of activity. The 100 most recent posts in the largest support groups were manually reviewed and further categorized into content subsections. A total number of 56 Facebook support groups were identified that satisfied the inclusion/exclusion criteria. Interstitial cystitis (IC) had 25 groups (68 466 members; 4825 posts), pelvic organ prolapse (POP) had 14 groups (72 342; 3067), UTI had nine groups (36 414; 3204), overactive bladder and/or urinary incontinence (OAB/UI) had seven groups (8246; 306), urinary retention had one group (1168; 118). Across all groups, post content was predominantly informational support (77.6%). Remaining post content was both informational and emotional support (10.0%), emotional support only (7.6%), or unrelated to either informational or emotional support (4.8%). Individuals with benign urologic conditions are utilizing social media support groups predominantly to seek and share informational support from patient peers. The number of existing groups as well as the level of activity and number of members within individual support groups varies significantly between different urologic conditions. This suggests that there is an unmet need for accessible informational content for patients who suffer with benign urological conditions.

Identifiants

pubmed: 37705338
doi: 10.1002/nau.25283
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1795-1801

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Abbas S, Singh AK. Media industry trends and dynamics: the social media boom. Procedia Soc Behav Sci. 2014;155:147-152. doi:10.1016/j.sbspro.2014.10.271
Ruby D 55+ Facebook Statistics For 2023 (Users, Revenue & Trends). Demand sage. February 10, 2023. Accessed March 30, 2023. https://www.demandsage.com/facebook-statistics/
Mo PK, Coulson NS. Exploring the communication of social support within virtual communities: A content analysis of messages posted to an online HIV/AIDS support group. Cyberpsychol Behav. 2008;11(3):371-374. doi:10.1089/cpb.2007.0118
Zrebiec JF, Jacobson AM. What attracts patients with diabetes to an Internet support group? A 21-month longitudinal website study: clinical practice. Diabetic Med. 2001;18(2):154-158. doi:10.1046/j.1464-5491.2001.00443.x
Coulson NS. Receiving social support online: an analysis of a computer-mediated support group for individuals living with irritable bowel syndrome. Cyberpsychol Behav. 2005;8(6):580-584. doi:10.1089/cpb.2005.8.580
Koo K., Ficko Z., Gormley A. Unprofessional content on Facebook accounts of US urology residency graduates. BJU Int. 2017;119(6):955-960. Accessed August 22, 2023. https://bjui-journals.onlinelibrary.wiley.com/doi/abs/10.1111/bju.13846?casa_token=P1pjEMAfQUcAAAAA%3AriQstukK8fdNBJ-xSt6xHCHrAh4ezpdYOHLUga6_8mDJbE0TdD0UEid0hfrdZmy7VKPrbCk6Cz4W9T4pgw
Loeb S, Carrick T, Frey C, Titus T. Increasing social media use in urology: 2017 American urological association survey. Eur Urol Focus. 2020;6(3):605-608. doi:10.1016/j.euf.2019.07.004
NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. Urologic diseases. Accessed August 3, 2022. https://www.niddk.nih.gov/health-information/urologic-diseases
Yu W, Ravelo A, Wagner TH, et al. Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev. 2003;60(3_suppl):146S-167S. doi:10.1177/1077558703257000
Bloom DE, Chen S, Kuhn M, McGovern ME, Oxley L, Prettner K. The economic burden of chronic diseases: estimates and projections for China, Japan, and South Korea. J. Econ Ageing. 2020;17:100163. doi:10.1016/j.jeoa.2018.09.002
PHA of Canada. Refining the measurement of the economic burden of chronic diseases in Canada. May 9, 2004. Accessed July 21, 2022. https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-25-no-1-2004/refining-measurement-economic-burden-chronic-diseases-canada.html
Rees J, O'boyle C, Macdonagh R. Quality of life: impact of chronic illness on the partner. J R Soc Med. 2001;94(11):563-566. doi:10.1177/014107680109401103
Scott KM, Lim C, Al-Hamzawi A, et al. Association of mental disorders with subsequent chronic physical conditions: world mental health surveys from 17 countries. JAMA Psychiatry. 2016;73(2):150-158. doi:10.1001/jamapsychiatry.2015.2688
Scott KM, Bruffaerts R, Tsang A, et al. Depression-anxiety relationships with chronic physical conditions: results from the world mental health surveys. J Affect Disord. 2007;103(1):113-120. doi:10.1016/j.jad.2007.01.015
Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540-544. doi:10.1016/j.juro.2011.03.132
Walker GJA, Gunasekera P. Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors. Int Urogynecol J. 2011;22(2):127-135. doi:10.1007/s00192-010-1215-0
Milsom I, Gyhagen M. The prevalence of urinary incontinence. Climacteric. 2019;22(3):217-222. doi:10.1080/13697137.2018.1543263
Rothrock NE, Lutgendorf SK, Kreder KJ. Coping strategies in patients with interstitial cystitis: relationships with quality of life and depression. J Urol. 2003;169(1):233-236. doi:10.1016/S0022-5347(05)64075-X
McCormick NB. When pleasure causes pain: living with interstitial cystitis. Sexuality and Disability. 1999;17:7-18.
Rothrock NE, Lutgendorf SK, Hoffman A, Kreder KJ. Depressive symptoms and quality of life in patients with interstitial cystitis. J Urol. 2002;167(4):1763-1767. doi:10.1016/S0022-5347(05)65195-6
Kinsey D, Pretorius S, Glover L, Alexander T. The psychological impact of overactive bladder: a systematic review. J Health Psychol. 2016;21(1):69-81. doi:10.1177/1359105314522084
Stewart W, Van Rooyen J, Cundiff G, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327-336. doi:10.1007/s00345-002-0301-4
Andersson KE, Appell R, Cardozo LD, et al. The pharmacological treatment of urinary incontinence. BJU Int. 1999;84(9):923-947. doi:10.1046/j.1464-410x.1999.00397.x
Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;2018(10):10. doi:10.1002/14651858.CD005654.pub4
American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome (2022). 2022. Accessed March 30, 2023. https://www.auanet.org/guidelines-and-quality/guidelines/diagnosis-and-treatment-interstitial-of-cystitis/bladder-pain-syndrome-(2022)
For Patients | Society of Urodynamics, Female pelvic medicine & urogenital reconstruction. Accessed April 26, 2023. https://sufuorg.com/resources/patients.aspx
Online Support Groups | Interstitial Cystitis Association. October 7, 2021. Accessed March 30, 2023. https://www.ichelp.org/living-with-ic/support-community/online-support-groups/
Oh SJ, Hyeon Ku J, Gyun Jeon H, Shin HI, Paik NJ, Yoo T. Health-related quality of life of patients using clean intermittent catheterization for neurogenic bladder secondary to spinal cord injury. Urology. 2005;65(2):306-310. doi:10.1016/j.urology.2004.09.032

Auteurs

Omar K Farah (OK)

Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

Connie N Wang (CN)

Department of Urology, Columbia University Irving Medical Center, New York, New York, USA.

Doreen E Chung (DE)

Department of Urology, Columbia University Irving Medical Center, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH